Pocket Naloxone Corp.


Pinova Therapeutics is developing a simple, cost-effective, and ready-to-use Naloxone product with a patented novel dosage form. Their mission is to provide accessible and affordable OTC Naloxone to prevent opioid overdose deaths, removing barriers such as stigma, pharmacist confusion, and high prices. They aim to combat the overdose crisis with innovative solutions and are actively pursuing FDA approval for OTC Naloxone products.

Industries

manufacturing
medical
pharmaceutical

Nr. of Employees

small (1-50)

Pocket Naloxone Corp.

Bethesda, Maryland, United States, North America


Products

Over‑the‑counter nasal swab emergency rescue product (opioid antagonist)

A ready‑to‑use single‑use nasal swab dosage form intended to deliver an opioid antagonist rapidly for emergency opioid overdose reversal; clinical PK data reported higher early systemic exposure compared with some comparator routes.


Services

Clinical evaluation (pharmacokinetic and human factors studies)

Design and execution of human factors validation studies and pharmacokinetic clinical studies to assess usability and early systemic exposure of a single‑use nasal swab dosage form.

OTC product commercialization strategy

Development of retail distribution, pricing, and access strategies to enable over‑the‑counter availability of an emergency nasal swab rescue product.

Expertise Areas

  • Emergency dosage form design (nasal swab formats)
  • Intranasal drug delivery and rapid‑absorption formulation
  • Clinical pharmacokinetics and PK study execution
  • Human factors and usability evaluation for emergency medical products
  • Show More (3)

Key Technologies

  • Nasal swab drug delivery
  • Intranasal rapid‑absorption formulation
  • Clinical pharmacokinetic study methods
  • Human factors/usability testing protocols
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.